Current Opinion in HIV and AIDS

Scope & Guideline

Empowering professionals with vital clinical insights.

Introduction

Delve into the academic richness of Current Opinion in HIV and AIDS with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1746-630x
PublisherLIPPINCOTT WILLIAMS & WILKINS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2007 to 2024
AbbreviationCURR OPIN HIV AIDS / Curr. Opin. HIV AIDS
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103

Aims and Scopes

The journal 'Current Opinion in HIV and AIDS' aims to provide a comprehensive overview of the latest developments in the field of HIV research, focusing on both clinical and basic science. The scope encompasses a variety of interdisciplinary approaches to understand HIV infection, its treatment, and related comorbidities.
  1. Microbiome and HIV Interactions:
    A core focus of the journal is the examination of the microbiome's role in HIV infection and disease progression, including its impact on transmission dynamics and therapeutic strategies.
  2. Innovative Therapeutic Strategies:
    The journal consistently highlights advancements in therapeutic approaches, including immunotherapy, gene therapy, and novel drug delivery systems, aimed at achieving HIV remission and eradication.
  3. HIV Comorbidities and Public Health:
    Research on the intersection of HIV with other health conditions, particularly chronic diseases like obesity and cardiovascular issues, is a critical area of focus, underscoring the need for comprehensive patient care.
  4. Vaccine Development and Prevention Strategies:
    The journal emphasizes the ongoing efforts in HIV vaccine research and prevention strategies, exploring both traditional and novel methodologies to enhance vaccine efficacy.
  5. Social and Behavioral Aspects of HIV:
    A significant aim is to address the social determinants of health and behavioral sciences in HIV prevention and care, recognizing the importance of contextual factors in addressing the HIV epidemic.
The journal has identified several emerging themes that reflect the latest trends in HIV research, highlighting innovative approaches and interdisciplinary collaborations.
  1. Microbiome Research:
    Recent publications reveal a growing interest in understanding the microbiome's influence on HIV risk, disease progression, and therapeutic outcomes, showcasing its potential as a target for intervention.
  2. Immunotherapy and Novel Treatment Approaches:
    There is an upward trend in research focusing on immunotherapy, including CAR-T cells and therapeutic vaccines, as promising strategies for achieving long-term HIV control and potential cures.
  3. Intersection of HIV with Other Epidemics:
    Research examining the interplay between HIV and other global health issues, such as COVID-19, is on the rise, reflecting a need for integrated responses to multiple public health challenges.
  4. Long-Acting Antiretroviral Therapies:
    The development and implementation of long-acting formulations for HIV treatment and prevention are increasingly prominent, suggesting a shift towards patient-centered care and adherence strategies.
  5. Social Determinants of Health in HIV:
    There is a growing emphasis on the social and behavioral determinants of health as critical components in addressing HIV prevention and treatment, highlighting the importance of context in health outcomes.

Declining or Waning

While the journal has a broad and evolving scope, certain themes have shown a decline in focus over the years, reflecting shifts in research priorities and advancements in the field.
  1. Traditional Antiretroviral Therapies:
    There is a noticeable decrease in publications focusing solely on traditional antiretroviral therapies, as research shifts towards more innovative treatment modalities and strategies for HIV eradication.
  2. HIV Criminalization and Legal Issues:
    Research concerning the legal aspects of HIV, including criminalization, has become less prevalent, possibly due to a growing emphasis on public health approaches rather than punitive measures.
  3. Focus on HIV in Isolation:
    The journal has moved away from studies that treat HIV as a standalone issue, increasingly integrating discussions about comorbidities and the broader health context in which HIV occurs.

Similar Journals

World Journal of Hepatology

Transforming liver disease understanding through open access.
Publisher: BAISHIDENG PUBLISHING GROUP INCISSN: 1948-5182Frequency: 12 issues/year

World Journal of Hepatology is a premier academic journal dedicated to advancing the field of hepatology. Published by BAISHIDENG PUBLISHING GROUP INC, this journal serves as a crucial platform for disseminating innovative research findings and critical reviews from around the globe. With its ISSN 1948-5182 and E-ISSN 1948-5182, the journal has established a notable presence since its inception in 2009, covering a wide range of topics relevant to liver diseases, including but not limited to hepatitis, liver cancer, and metabolic liver disorders. Currently ranked 41/82 in the field of hepatology by Scopus, representing the 50th percentile, it has achieved a Q3 quartile ranking in the 2023 category, underscoring its growing influence in the medical community. With a commitment to open access for its readership, the World Journal of Hepatology enriches the global discourse on liver health and disease management, making it an essential resource for researchers, clinicians, and students alike.

HIV MEDICINE

Exploring Breakthroughs in HIV Medicine and Policy
Publisher: WILEYISSN: 1464-2662Frequency: 10 issues/year

HIV Medicine is a prestigious journal published by Wiley that stands at the forefront of research in the fields of health policy, infectious diseases, and pharmacology, with a commendable impact factor reflected in its Q1 rankings for 2023. Established in 1999 and set to converge its expertise through 2024, this journal plays a critical role in advancing the understanding and treatment of HIV and related health challenges. It is esteemed for its rigorous peer-review process and its contributions to both clinical and policy-oriented discussions surrounding HIV medicine. With a broad international readership, it serves as a vital resource for researchers, healthcare professionals, and students committed to fighting the global HIV epidemic. Although not open access, its vital insights are indispensable for anyone involved in infectious disease research and healthcare policy. Articles published in HIV Medicine shape global health strategies and influence the future of HIV research, making it a must-read for those dedicated to this crucial field.

Annals of Geriatric Medicine and Research

Transforming insights into impactful care for seniors.
Publisher: KOREAN GERIATRIC SOCISSN: 2508-4909Frequency: 4 issues/year

Annals of Geriatric Medicine and Research, published by the Korean Geriatric Society, is a premier open-access journal dedicated to advancing the understanding of geriatric medicine and gerontology. Since its inception in 1997, the journal has played a crucial role in disseminating significant research findings, policy discussions, and clinical innovations that address the complexities of elderly healthcare. Based in South Korea, the journal has gained recognition with an impact factor reflecting its Q2 ranking in the field of Geriatrics and Gerontology for 2023, placing it competitively within its category among 116 journals. Researchers, healthcare professionals, and students will find comprehensive insights ranging from clinical studies to public health strategies crucial for enhancing the quality of life of older adults. With a commitment to open access, the journal ensures that its valuable information is freely available, fostering collaboration and knowledge-sharing that is vital in this dynamic field.

Cardiovascular Journal of Africa

Championing cardiovascular health for African populations.
Publisher: CLINICS CARDIVE PUBL PTY LTDISSN: 1995-1892Frequency: 6 issues/year

Welcome to the Cardiovascular Journal of Africa, an esteemed publication dedicated to advancing the fields of Cardiology and Cardiovascular Medicine. Established in 1994 and published by CLINICS CARDIVE PUBL PTY LTD, this journal serves as a vital platform for researchers, practitioners, and students interested in innovative cardiovascular research and clinical practice within the African context and beyond. With a Q3 ranking in both relevant categories as of 2023, this journal contributes significantly to the growing corpus of medical literature. Although access is non-open, the journal features a diverse array of peer-reviewed articles that explore groundbreaking findings and practical applications in cardiovascular health, fostering knowledge exchange among professionals. Situated in South Africa, the Cardiovascular Journal of Africa is not just a repository of academic research; it is a cornerstone in the fight against cardiovascular diseases, addressing the unique challenges faced by populations across the continent.

HEMOGLOBIN

Bridging academia and clinical practice in hematology.
Publisher: TAYLOR & FRANCIS LTDISSN: 0363-0269Frequency: 6 issues/year

HEMOGLOBIN, a prominent journal published by Taylor & Francis Ltd, serves as a vital resource in the fields of Biochemistry, Clinical Biochemistry, Genetics, and Hematology. Established in 1976, the journal provides a platform for innovative research and review articles that explore the complexities of hemoglobin pathology and related disorders, making significant contributions to our understanding of hematological diseases. With an ISSN of 0363-0269 and an E-ISSN of 1532-432X, HEMOGLOBIN has garnered attention within the academic community, reflected in its category quartiles for 2023, which rank it in the Q3 and Q4 levels across relevant medical and biochemistry categories. Although it operates on a subscription basis rather than as an open-access journal, it remains influential, providing critical insights to researchers, professionals, and students aiming to address the current challenges in blood research and related fields. The journal not only emphasizes high-quality scientific analyses but also seeks to foster collaboration and dialogue among academia and clinical practitioners, ultimately advancing the frontier of knowledge in hemoglobin and hematological research.

BIOMEDICINE & PHARMACOTHERAPY

Pioneering insights for better health outcomes.
Publisher: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIERISSN: 0753-3322Frequency: 12 issues/year

BIOMEDICINE & PHARMACOTHERAPY is a distinguished journal published by Elsevier France - Éditions Scientifiques Médicales Elsevier, specializing in the essential fields of medicine and pharmacology. Established in 1982 and covering literature up to 2024, this journal is notably recognized for its impact, holding a prestigious Q1 ranking in both Medicine (Miscellaneous) and Pharmacology, as well as a commendable position within the top 10% of its category based on Scopus rankings. Researchers and practitioners will find it serves as a vital resource for the latest advancements, innovations, and critical reviews in the life sciences and therapeutic practices. The journal emphasizes rigorous peer review and high-quality publications, aimed at facilitating knowledge dissemination in biomedicine and pharmacotherapy. Its commitment to excellence makes it an indispensable platform for contributors and readers alike who are engaged in improving health outcomes through pharmaceutical research and medical advances.

JANAC-JOURNAL OF THE ASSOCIATION OF NURSES IN AIDS CARE

Pioneering Research for a Healthier Tomorrow in AIDS Care
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1055-3290Frequency: 6 issues/year

JANAC - Journal of the Association of Nurses in AIDS Care is a premier peer-reviewed publication dedicated to the advancement of knowledge and practice in the field of AIDS nursing. Published by the esteemed Lippincott Williams & Wilkins, this journal has established itself as a crucial resource for researchers, clinicians, and educators since its inception in 1991. With an impressive Q1 ranking in Advanced and Specialized Nursing and a Scopus rank of 14 out of 63, JANAC stands at the forefront of scholarly communication, reflecting its high impact and relevance in the nursing community. The journal aims to disseminate groundbreaking research, innovative practices, and comprehensive reviews that address the unique challenges faced in AIDS care, making it an indispensable tool for those committed to improving health outcomes for individuals affected by HIV/AIDS. While not an Open Access journal, JANAC continues to foster knowledge exchange through its rigorous editorial process and diverse publication options, ensuring that important findings reach practitioners and policymakers alike.

AIDS REVIEWS

Delivering comprehensive insights into AIDS advancements.
Publisher: PERMANYER PUBLISSN: 1139-6121Frequency: 4 issues/year

AIDS REVIEWS, published by Permanyer Publishing, is a distinguished academic journal dedicated to providing comprehensive insights into the field of AIDS research. Since its inception in 2000, the journal has served as a vital platform for disseminating knowledge on various aspects of HIV/AIDS, including prevention, treatment advancements, and socio-medical implications. With a commendable Q3 ranking in both Infectious Diseases and Medicine (miscellaneous), as well as Pharmacology (medical) in 2023, the journal has made significant strides in the academic community, covering relevant topics and emerging trends up to 2024. Although not open access, AIDS REVIEWS continues to attract contributions from leading researchers and professionals, fostering a collaborative environment aimed at improving health outcomes related to AIDS. Located in Barcelona, Spain, this journal is an essential resource for anyone dedicated to advancing their understanding of this global health challenge.

Biomolecules and Biomedicine

Innovating Insights in Biomedical Research
Publisher: ASSOC BASIC MEDICAL SCI FEDERATION BOSNIA & HERZEGOVINA SARAJEVOISSN: 2831-0896Frequency: 6 issues/year

Biomolecules and Biomedicine is a pioneering open-access journal dedicated to advancing the fields of molecular biology and biomedical sciences, published by the Association of Basic Medical Science Federation Bosnia & Herzegovina in Sarajevo. With the ISSN 2831-0896 and the E-ISSN 2831-090X, this journal aims to facilitate the dissemination of high-quality research from 2023 onwards, inviting submissions that provide innovative insights and findings across various facets of medicine and biological sciences. Positioned within the General Medicine and Biochemistry, Genetics and Molecular Biology categories, it currently holds rankings of 332 out of 636 and 173 out of 221 respectively, highlighting its emerging influence in these fields. As an open-access journal, it ensures that all published research is freely accessible to a global audience, fostering collaboration and knowledge exchange among researchers, professionals, and students alike. With a commitment to enhancing scientific discourse and promoting cutting-edge research, Biomolecules and Biomedicine is poised to become a vital resource for those dedicated to unraveling the complexities of biomolecules and their roles in health and disease.

JOURNAL OF MEDICAL VIROLOGY

Elevating Research Standards: A Premier Source in Medical Virology.
Publisher: WILEYISSN: 0146-6615Frequency: 12 issues/year

JOURNAL OF MEDICAL VIROLOGY is a prestigious academic publication dedicated to advancing the field of virology and infectious diseases. Published by WILEY, this journal has established itself as a cornerstone within the scientific community since its inception in 1977, and it will continue to provide cutting-edge research until 2024. With an impressive impact factor that places it in the Q1 quartile for both Infectious Diseases and Virology, the journal ranks 14 out of 344 in Medicine - Infectious Diseases and 6 out of 80 in Immunology and Microbiology - Virology according to Scopus metrics. Its focus encompasses a broad spectrum of topics, including viral pathogenesis, diagnostics, treatment strategies, and epidemiology, making it an essential resource for researchers, clinicians, and students alike. Although not an open-access journal, it provides valuable insights and accessible content for subscribers and libraries. The ongoing commitment to high-quality peer-reviewed articles makes JOURNAL OF MEDICAL VIROLOGY a vital platform for disseminating knowledge and fostering innovation in virology and related fields.